IMD-3-1498 © 2005
Yaziji, Michael; Lindblom, Anna
The C- part of the cases concentrates on the actions GSK needed to take being pressed by the NGOs. The business had actually been beat and it consented to numerous licensing arrangements and rate decreases; however the NGOs are still not pleased.
The subject was likewise getting value in the Western media and the huge concern now was whether it was beginning to end up being a concern in more industrialized nations; where the huge bulk of GSKs' revenues and sales were being made.
Subjects: NGOs; Non-market competition; Ethics;Pharmaceutical; AIDS;Patents
Settings: South Africa; Pharmaceutical; Largest pharmaceutical company in the world; >100;000 employees; 2001 - 2004
Related Case Solutions & Analyses:
Coach K: Matter of the Heart
Engine Services Inc.
Indirect Competition: Strategic Considerations
Extending an Electronic Trade Network to Sustain Competitive Advantage
Interview with Heidi Roizen Video
Davis Boatworks
ConAgra Inc.: Across the Food Chain
Omar Ishrak: Building Medtronic Globally
Friendly Cards, Inc.
Paperless Healthcare: Progress and Challenges of an IT-Enabled Healthcare System
